The patented Safe-2-Dose™ Integrated Dosing Container is the next generation Infants elixir dispenser providing enhanced medication dosing accuracy and user convenience. The caregiver need only disabl
The Safe-T-Fuse™ is an industry unique patented infusion container that allows the contents of a standard vial to be quickly introduced to an integrated reservoir without any additional components.
By design, the device allows a user to precisely control the volume and duration of the reconstitution and subsequent closed system transfer of the medication to its reservoir.
The Safe-T-Fuse’s™ ability to introduce multiple metered doses prior to or during a patient’s infusion enhances safety and efficacy through ultra-precise calibrated dosing.
The Safe-T-Fuse™ has an advanced containment sleeve cap which encapsulates the vial transfer compartment to prevent aerosolization of a medication during the transfer from the vial to the reservoir.
The pre-loaded Safe-T-Fuse™ provides a tamper resistant feature that secures the vial within the sleeve cap preventing it from being accessed or removed. To engage the vial, a security clip is removed and the sleeve cap is depressed to allow a bi-directional transfer of medication and diluent.
The Safe-T-Fuse™ may be designed for a administering a fixed dose or adjustable dose infusion. The combined passive safety features of the The Safe-T-Fuse™ prevent sharp injuries, incorrect diluent reconstitution and reduces dosage calculation error.
Not available in all territories.
Safe-T-Fuse™ is a trademark of Asepsis Medical Technologies, LLC., and covered by two or more patents, including; U.S. Patent 9,433,726 and U.S Patent 11,058,606, as well as Patents Pending.
Video
Technical Video
Latest News
Asepsis Announces The Grant Of Mexico Patent No. 384,129
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-
Asepsis Announces the Grant of Canadian Patent No. 3,006,218
Asepsis Medical Technologies® is proud to announce their latest Canadian Patent Grant 3,006,218 of August 24, 2021 – for the multi-dose oral Dose-2-Weight Syringe®. The Dose-2-Weight Sy
Asepsis announces the US Patent Grant 11,058,606
Asepsis Medical Technologies announces the USPTO issuance of Patent Application Number 11,058,606 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion contai
Asepsis Announces the Grant of Mexico Patent MX/a/2017/012034
The Safe-T-Syringe® is designed to deliver the highest standard of patient care via syringe. Its medication calibrated indicia provide enhanced accuracy, convenience and safety through-out preparation
Asepsis Announces the Grant of U.S. Patent 10,857,299
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-Dose® syringe provid
Asepsis Announces the U.S. Patent Grant No. 10,625,026
Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The Momenta Dose™ is designed to administer rapid small volume subcutaneous or intra